Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Martin K. Christensen"'
Autor:
Lars Jakobsen, Evald H. Christiansen, Phillip Freeman, Johnny Kahlert, Karsten Veien, Michael Maeng, Bent Raungaard, Julia Ellert, Steen D. Kristensen, Martin K. Christensen, Christian J. Terkelsen, Troels Thim, Ashkan Eftekhari, Rebekka V. Jensen, Nicolaj B. Støttrup, Anders Junker, Henrik S. Hansen, Lisette O. Jensen
Publikováno v:
Jakobsen, L, Christiansen, E H, Freeman, P, Kahlert, J, Veien, K, Maeng, M, Raungaard, B, Ellert, J, Kristensen, S D, Christensen, M K, Terkelsen, C J, Thim, T, Eftekhari, A, Jensen, R V, Støttrup, N B, Junker, A, Hansen, H S & Jensen, L O 2023, ' Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent ', Catheterization and Cardiovascular Interventions, vol. 101, no. 1, pp. 13-21 . https://doi.org/10.1002/ccd.30480
OBJECTIVES: To compare the efficacy and safety of the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent (DTS) and the sirolimus-eluting Orsiro stent (O-SES) in patients with and without acute coronary syndrome (ACS) included in the SOR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a328322cab723340935d6d4ac01587
https://pure.au.dk/portal/da/publications/impact-of-acute-coronary-syndrome-on-clinical-outcomes-after-revascularization-with-the-dualtherapy-cd34-antibodycovered-sirolimuseluting-combo-stent-and-the-sirolimuseluting-orsiro-stent(f41888cf-79e5-49c0-9b19-4854f821239d).html
https://pure.au.dk/portal/da/publications/impact-of-acute-coronary-syndrome-on-clinical-outcomes-after-revascularization-with-the-dualtherapy-cd34-antibodycovered-sirolimuseluting-combo-stent-and-the-sirolimuseluting-orsiro-stent(f41888cf-79e5-49c0-9b19-4854f821239d).html
Autor:
Lars Jakobsen, Evald H. Christiansen, Phillip Freeman, Johnny Kahlert, Karsten Veien, Michael Maeng, Bent Raungaard, Julia Ellert, Steen D. Kristensen, Martin K. Christensen, Christian J. Terkelsen, Troels Thim, Ashkan Eftekhari, Rebekka V. Jensen, Nicolaj B. Støttrup, Anders Junker, Henrik S. Hansen, Lisette O. Jensen
Publikováno v:
Jakobsen, L, Christiansen, E H, Freeman, P, Kahlert, J, Veien, K, Maeng, M, Raungaard, B, Ellert, J, Kristensen, S D, Christensen, M K, Terkelsen, C J, Thim, T, Eftekhari, A, Jensen, R V, Støttrup, N B, Junker, A, Hansen, H S & Jensen, L O 2022, ' Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent ', Catheterization and Cardiovascular Interventions, vol. 99, no. 7, pp. 1965-1975 . https://doi.org/10.1002/ccd.30175
OBJECTIVES: To compare the efficacy and safety of the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent (DTS) and the sirolimus-eluting Orsiro stent (SES) in patients with and without diabetes mellitus (DM) included in the Scandinavian
Publikováno v:
The Journal of invasive cardiology. 33(4)
A 46-year-old man with type 1 diabetes underwent percutaneous coronary intervention with bioresorbable scaffold implantation for a long segment of physiologically significant left anterior descending coronary artery disease. The procedure was complic